• STJ73751 (2µg/ml) staining of HeLa (A) , HepG2 (B) and U2OS (C) cell lysate (35µg protein in RIPA buffer). Detected by chemiluminescence.
  • STJ73751 Immunofluorescence analysis of paraformaldehyde fixed MCF7 cells, permeabilized with 0. 15% Triton. Primary incubation 1hr (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml) , showing cell junction staining. The nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10ug/ml) followed by Alexa Fluor 488 secondary antibody (2ug/ml).

Anti-SCRIB/Scribble antibody (Internal) (STJ73751)

SKU:
STJ73751-100

Shipping:
Free Shipping
Current Stock:
Host: Goat
Applications: Pep-ELISA/WB/IF
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Goat polyclonal antibody anti-SCRIB/Scribble (Internal) is suitable for use in ELISA, Western Blot and Immunofluorescence research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA
Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Concentration: 0.5 mg/mL
Dilution Range: WB-1-3µg/ml
IF-Strong expression of the protein seen in the cell junctions of MCF7 cells. 10µg/ml
ELISA-antibody detection limit dilution 1:1000.
Storage Instruction: Store at-20°C on receipt and minimise freeze-thaw cycles.
Gene Symbol: SCRIB
Gene ID: 23513
Uniprot ID: SCRIB_HUMAN
Immunogen Region: Internal
Accession Number: NP_874365.3; NP_056171.3
Specificity: This antibody is expected to recognize both reported isoforms (NP_874365.3; NP_056171.3).
Immunogen Sequence: PEGPGKEKELPGQ
Post Translational Modifications Ubiquitinated.targeted for UBE3A-dependent multiubiquitination in the presence of high-risk HPV E6 proteins and degraded. Palmitoylated. Could be depalmitoylated by LYPLA1 and/or LYPLA2. Palmitoylation of SCRIB by ZDHHC7 is required for its localization to cell-cell junctions, function in the establishement of epithelial cell polarity and the regulation of downstream signaling pathways important for epithelial cell differentiation.
Function Scaffold protein involved in different aspects of polarized cell differentiation regulating epithelial and neuronal morphogenesis and T-cell polarization. Via its interaction with CRTAM, required for the late phase polarization of a subset of CD4+ T-cells, which in turn regulates TCR-mediated proliferation and IFNG and IL22 production. Most probably functions in the establishment of apico-basal cell polarity. May function in cell proliferation regulating progression from G1 to S phase and as a positive regulator of apoptosis for instance during acinar morphogenesis of the mammary epithelium. May also function in cell migration and adhesion and hence regulate cell invasion through MAPK signaling. May play a role in exocytosis and in the targeting of synaptic vesicles to synapses. Functions as an activator of Rac GTPase activity.
Protein Name Protein Scribble Homolog
Scribble
Hscrib
Protein Lap4
Database Links Reactome: R-HSA-4608870
Reactome: R-HSA-9013148
Reactome: R-HSA-9013406
Reactome: R-HSA-9013409
Reactome: R-HSA-9696264
Reactome: R-HSA-9696270
Cellular Localisation Cell Membrane
Peripheral Membrane Protein
Cell Junction
Adherens Junction
Cell Projection
Lamellipodium
Cytoplasm
Postsynapse
Presynapse
Targeting To Cell-Cell Junctions Which Is Cdh1-Dependent Is Required For The Pro-Apoptotic Activity
In A Subset Of Cd4+ T-Cells
Colocalizes With Crtam At The Immunological Synapse During The Late Phase Of T-Cell Activation
Alternative Antibody Names Anti-Protein Scribble Homolog antibody
Anti-Scribble antibody
Anti-Hscrib antibody
Anti-Protein Lap4 antibody
Anti-SCRIB antibody
Anti-CRIB1 antibody
Anti-KIAA0147 antibody
Anti-LAP4 antibody
Anti-SCRB1 antibody
Anti-VARTUL antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance